Remdesivir Is Effective in Combating COVID-19 because It Is a Better Substrate than ATP for the Viral RNA-Dependent RNA Polymerase

COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and is currently being treated using Remdesivir, a nucleoside analog that inhibits the RNA-dependent-RNA polymerase (RdRp). However, the enzymatic mechanism and efficiency of Remdesivir have not been determined, a...

Descripción completa

Detalles Bibliográficos
Autores principales: Dangerfield, Tyler L., Huang, Nathan Z., Johnson, Kenneth A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695572/
https://www.ncbi.nlm.nih.gov/pubmed/33283177
http://dx.doi.org/10.1016/j.isci.2020.101849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7695572/
https://www.ncbi.nlm.nih.gov/pubmed/33283177
http://dx.doi.org/10.1016/j.isci.2020.101849

Ejemplares similares